XRCC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.89960269736389E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.34281474828413E-12 |
Normal-vs-Stage2 |
1.172220E-02 |
Normal-vs-Stage3 |
3.74339999997808E-06 |
Normal-vs-Stage4 |
6.16020000010487E-07 |
Stage1-vs-Stage2 |
1.287830E-01 |
Stage1-vs-Stage3 |
3.018000E-02 |
Stage1-vs-Stage4 |
4.040600E-01 |
Stage2-vs-Stage3 |
8.196600E-01 |
Stage2-vs-Stage4 |
3.857400E-01 |
Stage3-vs-Stage4 |
3.226400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.26439977879522E-10 |
Normal-vs-AfricanAmerican |
2.82599999956723E-07 |
Normal-vs-Asian |
2.597100E-03 |
Caucasian-vs-AfricanAmerican |
2.662300E-02 |
Caucasian-vs-Asian |
6.845800E-01 |
AfricanAmerican-vs-Asian |
3.415600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.31589994456505E-09 |
Normal-vs-Female |
1.49610324129412E-11 |
Male-vs-Female |
1.698030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.875600E-03 |
Normal-vs-Age(41-60Yrs) |
6.04090111266942E-11 |
Normal-vs-Age(61-80Yrs) |
5.24710053184663E-10 |
Normal-vs-Age(81-100Yrs) |
2.615200E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.352400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.831400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.884400E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.751400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.076100E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.677600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.65134614052931E-12 |
Normal-vs-Grade 2 |
3.67109675991628E-11 |
Normal-vs-Grade 3 |
3.82810000365552E-08 |
Normal-vs-Grade 4 |
1.9963299999981E-05 |
Grade 1-vs-Grade 2 |
1.422450E-03 |
Grade 1-vs-Grade 3 |
3.72980000000744E-05 |
Grade 1-vs-Grade 4 |
3.795200E-04 |
Grade 2-vs-Grade 3 |
1.058420E-01 |
Grade 2-vs-Grade 4 |
3.815400E-01 |
Grade 3-vs-Grade 4 |
7.835600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.19935181178244E-13 |
Normal-vs-ccB subtype |
3.809700E-04 |
ccA subtype-vs-ccB subtype |
3.387500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.05469999797958E-08 |
Normal-vs-N1 |
7.759900E-04 |
N0-vs-N1 |
7.186200E-01 |
|
|